Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study

著者: Irene Braña, Antonio Calles, Patricia LoRusso, Lorrin Yee, Thomas A. Puchalski, Shobha Seetharam, Bob Zhong, Carla J. de Boer, Josep Tabernero, Emiliano Calvo - Targeted Oncology 2014 被引用: 210